Drug
Avi 4658 For
Avi 4658 For: highest development phase Phase 1/2, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AVI-4658 for Injection NCT00844597 | Phase 1/2 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Avi 4658 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.